Status:
UNKNOWN
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations
Lead Sponsor:
Tabula Rasa HealthCare
Collaborating Sponsors:
Cambia Health Solutions
Conditions:
COVID
Drug Effect
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective study aims to perform a medication risk stratification using drug claims data and to simulate the impact of the addition of various repurposed drugs on the Medication Risk Score (MR...
Detailed Description
Certain investigational agents have been described in observational series or are being used anecdotally based on in vitro or extrapolated evidence. It is important to acknowledge that there are no co...
Eligibility Criteria
Inclusion
- Patients enrolled with Cambia Health Solutions; Medicare/Medicaid or Commercial Health Insurance Plan
- Patients with drug claims available from 10/01/2018 to 10/31/2019
Exclusion
- Patients with no drug claims available for 2018
- Health Plan for injectable drugs
Key Trial Info
Start Date :
June 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 11 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04378881
Start Date
June 12 2020
End Date
November 11 2023
Last Update
September 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute
Orlando, Florida, United States, 32827